Stephan Krause
Executive Director - Analytical Quality Bristol Myers Squibb
Stephan O. Krause, Ph.D., is Executive Director, Analytical Science and Technology, Cell Therapy Global Quality at Bristol Myers Squibb, where he leads analytical strategy and quality lifecycle execution for global cell therapy products. He is a member of PDA’s Board of Directors, chair of PDA’s ATMP Advisory Board, and chair of the ANSI task force (ANS-007) for analytical lifecycle steps. Dr. Krause is an accomplished advocate for advancing industry best practices and has received numerous awards for innovation and leadership.
